Skip to content
Discovery on Target 2015 | Targeting DUBs episode artwork

Jun 3, 2015 13 min

Discovery on Target 2015 | Targeting DUBs

from CHI Podcasts Hosted by Cambridge Healthtech Podcasts

CHI interviews Dr. Xavier Jacq, Head of Biology at MISSION Therapeutics regarding drugging deubiquitinase enzymes (DUBs), a rapidly emerging target class with the Ubiquitin Proteasome System (UPS). Discussion topics and questions include: 1. Tell us a little about MISSION and your current programs. 2. Why are these emerging as viable therapeutic targets? 3. What are drug discovery challenges in this space? What about inhibitor discovery, how challenging is this? 4. What might be challenges surrounding translating these compounds into the clinic? 5. What are some novel tools and technologies being developed to overcome some of these challenges? 6. You are giving a lecture at the 13th Annual Discovery on Target Conference, during the Targeting the Ubiquitin Proteasome System meeting. What do you hope to convey to attendees during your lecture this fall? 7. How have you seen this field evolve over the past few years, and where do you see it going in the future? For more information visit http://www.DiscoveryOnTarget.com/

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Discovery on Target 2015 | Targeting DUBs

0:00 13:30

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of CHI Podcasts?

This episode is 13 minutes long.

When was this CHI Podcasts episode published?

This episode was published on June 3, 2015.

Can I download this CHI Podcasts episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.